Christopher H. Porter

Melbourne, VIC 3052, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 157 publications

Application of a glyceride-mimetic prodrug strategy to deliver protease inhibitors to gut lymph to alleviate organ failure.

Application of a glyceride-mimetic prodrug strategy to deliver protease inhibitors to gut lymph to alleviate organ failure.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 05, 2026

Application of a glyceride-mimetic prodrug strategy to deliver protease inhibitors to gut lymph to alleviate organ failure.

Application of a glyceride-mimetic prodrug strategy to deliver protease inhibitors to gut lymph to alleviate organ failure.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 05, 2026

An oral allopregnanolone prodrug bypasses liver metabolism via lymphatic transport enabling bioavailability in animals and humans.

An oral allopregnanolone prodrug bypasses liver metabolism via lymphatic transport enabling bioavailability in animals and humans.

Journal: Science translational medicine

Published: March 25, 2026

Dysfunctional adipose tissue-lymphatic crosstalk in obesity.

Dysfunctional adipose tissue-lymphatic crosstalk in obesity.

Journal: Nature reviews. Endocrinology

Published: February 27, 2026

The expanding role of formulations to enable oral delivery of poorly water-soluble drugs.

The expanding role of formulations to enable oral delivery of poorly water-soluble drugs.

Journal: Nature reviews. Drug discovery

Published: February 19, 2026

Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy.

Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy.

Journal: Cancer immunology research

Published: February 28, 2025

Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport.

Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport.

Journal: Molecular pharmaceutics

Published: February 11, 2025

Nanobody-Mediated Cellular Uptake Maximizes the Potency of Polylysine Dendrimers While Preserving Solid Tumor Penetration.

Nanobody-Mediated Cellular Uptake Maximizes the Potency of Polylysine Dendrimers While Preserving Solid Tumor Penetration.

Journal: ACS nano

Published: February 06, 2025

A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles.

A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles.

Journal: Nature nanotechnology

Published: July 31, 2024

Lymphatic Uptake of a Highly Lipophilic Protease Inhibitor Prodrug from a Lipid-Based Formulation is Limited by Instability in the Intestine.

Lymphatic Uptake of a Highly Lipophilic Protease Inhibitor Prodrug from a Lipid-Based Formulation is Limited by Instability in the Intestine.

Journal: Journal of pharmaceutical sciences

Published: February 09, 2024

Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions.

Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions.

Journal: Pharmacological reviews

Published: December 19, 2023

Increased In Vivo Exposure of N-(4-Hydroxyphenyl) Retinamide (4-HPR) to Achieve Plasma Concentrations Effective against Dengue Virus.

Increased In Vivo Exposure of N-(4-Hydroxyphenyl) Retinamide (4-HPR) to Achieve Plasma Concentrations Effective against Dengue Virus.

Journal: Pharmaceutics

Published: June 13, 2023

Showing 1-12 of 157

Last Updated: 09/26/2026